Skip to main content

Vistin Pharma ASA: Fourth quarter 2019 financial results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Oslo, Norway, 28 February 2020Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the fourth quarter of 2019, with a 40% increase in revenue and robust earnings in the pharmaceutical business unit and unrealised gains on oil derivatives of NOK 0.6 million.The revenues for the fourth quarter 2019 ended at NOK 56.8 million (Q4 2018: NOK 40.6 million).The net profit ended at NOK 4.2 million (-64.0) in the fourth quarter of 2019, which included an unrealised financial gain on oil derivatives portfolio of NOK 0.6 million (-65.2) for the period.Vistin Pharma had cash of NOK 319.6 million (320.7) as of 31 December 2019.The fourth quarter conference call, which will be held today, 28 February, at 8.30am (CEST) and will be available via web and audio through the following access points:Telephone conference:
Confirmation Code:…….. 6394327
International Dial-In:…….. +44 (0) 2071 928000
Norway, Oslo:……………. +47 23960264
United States, New York: +16315107495Webcast:
https://edge.media-server.com/mmc/p/zxt9i6wnThe conference call will be held in Norwegian.
       Please find the Q4 2019 Report and presentation enclosed. The report will also be made available on www.vistin.com.*****For further information, please contact:
Kjell-Erik Nordby
CEO
+47 91 36 42 80
kjell-erik.nordby@vistin.com
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
About Vistin Pharma | www.vistin.comVistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.AttachmentsVistin Pharma ASA fourth quarter presentation 2019Vistin Pharma ASA fourth quarter report 2019

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.